New Drug Shows Promise in Treating Ovarian Cancer
The experimental drug olaparib, which has been shown to be effective in treating ovarian cancer in patients with BRCA1 or BRCA2 gene mutations, also appears to work in some patients without the mutations.
Copyright 2012 Inergize Digital. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.